Particle Sciences, A Lubrizol Life Science Company
PharmaceuticalsPennsylvania, United States51-200 Employees
Particle Sciences, based in Bethlehem, Pennsylvania, operates as a mid-sized contract development and manufacturing organization serving the pharmaceutical sector. It offers a full range of services from formulation and GMP/GLP production to analytic and bioanalytic support, providing an integrated path designed to shorten development timelines and reduce risk between discovery and clinical testing. The company specializes in semisolids, suspensions, particulates, and drug/device products, with additional capabilities for sterile formulations and highly potent compounds, and it brings deep expertise in fine-particle and nanotechnology to tackle challenging APIs. With more than twenty years of experience, Particle Sciences delivers preformulation, formulation, analytical, and manufacturing work through a collaborative, responsive approach that aims to meet client objectives on time and within budget. In the pharmaceutical manufacturing landscape, Particle Sciences positions itself as a comprehensive development partner for drug developers seeking to advance candidates through early-stage development toward the clinic. Its client base comprises pharmaceutical companies that require end-to-end formulation, analytic, and clinical manufacturing services to minimize development risk and time to clinic. Recent developments include a January 2026 announcement of a strategic collaboration with DelAQUA Pharmaceuticals to integrate DelAQUA's polymeric micelle delivery platform into Particle Sciences' development offerings, and reference to Particle Sciences operating as a division within Agno Pharma, reflecting its current corporate context.